Is UroGen Pharma Ltd. (URGN) a Buy, Sell, or Hold?
UroGen Pharma Ltd.
NASDAQ:URGN
$39.19 USD
-$0.32 (-0.81%)
- Volume
- 633.48K
- Average Volume
- 814.44K
- Market Capitalization
- $1.91B
- P/E Ratio
- -14.25
- Dividend Yield
- 0.00%
- Price Target
- $42.50
- Year High
- $40.35
- Year Low
- $13.79
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $4.69
URGN vs. The Competition
| Properties | URGN | ANAB | BBOT | KOD |
|---|---|---|---|---|
| Market Cap | $1.91B | $2.7B | $706.54M | $2.29B |
| Shares Outstanding | $48.72M | $43.12M | $80.11M | $52.93M |
| P/E Ratio | -14.25 | -73.54 | -1.54 | -10.37 |
| EPS | -2.65 | -0.93 | -4.95 | -3.73 |
| Day Low | 38.8784 | 62.34 | 8.39 | 40.04 |
| Day high | 40.19 | 70 | 9.05 | 44.29 |
| Year Low | 13.79 | 11.404 | 7 | 4.39 |
| Year High | 40.35 | 72.36 | 14.87 | 47.84 |
| Average Price 50 | 30.9885 | 60.7778 | 8.137 | 37.1926 |
| Average Price 200 | 23.45793 | 39.77828 | 10.36725 | 28.4617 |
| Volume | 633.48K | 624.24K | 431.91K | 914.78K |
| Average Volume | - | - | - | - |